Sunday, November 1, 2026

USD/EUR Bullish Momentum: 0.81% Up In The Last 5 Sessions

USD/EUR Bullish Momentum: 0.81% Up In The Last 5 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 0.81% for the last 5 sessions. At 00:06 EST on Thursday, 13 June, USD/EUR (USDEUR) is $0.93.

USD/EUR's yearly highs and lows, it's 4.318% up from its 52-week low and 3.323% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was a positive 0.19%, a negative 0.02%, and a positive 0.27%, respectively.

USD/EUR's highest amplitude of average volatility was 0.40% (last week), 0.28% (last month), and 0.27% (last quarter), respectively.

News about

  • Usd/jpy extends upside on firmer US dollar, all eyes on US cpi, fed rate decision. According to FXStreet on Wednesday, 12 June, "The USD/JPY pair extends the rally near 157.15 during the early Asian trading hours on Wednesday. ", "In the meantime, the interest rate divergence between the US and Japan continues to undermine the Japanese Yen (JPY) against the USD and create a tailwind for the USD/JPY pair."
  • Usd/jpy trades with positive bias, remains below 157.00 as focus shifts to boj meeting. According to FXStreet on Thursday, 13 June, "Apart from this, the broader risk sentiment, which tends to drive demand for the safe-haven Japanese Yen (JPY) might provide some impetus to the USD/JPY pair.", "Nevertheless, the shift in the Fed's projections should underpin the USD and support prospects for a further appreciating move for the USD/JPY pair. "
  • Usd/jpy price analysis: struggles at 157.00, drops and remains subdued. According to FXStreet on Tuesday, 11 June, "Conversely, if USD/JPY buyers lift the exchange rate past the 157.00 figure, the next resistance would be the May 29 high of 157.71. ", "The USD/JPY retreats during the North American session yet is virtually unchanged as traders brace for Wednesday's busy economic docket, which will feature May's US Consumer Price Index (CPI) data and the Federal Open Market Committee (FOMC) monetary policy decision. "
  • According to FXStreet on Wednesday, 12 June, "The interest rate divergence between the US and Japan continues to undermine the Japanese Yen (JPY), creating a tailwind for the USD/JPY pair.", "A breach below this level might intensify downward pressure on the USD/JPY pair, potentially directing it toward the throwback support area around 152.80."

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com